| EVIDENCE
WATCH
A review and assessment of recent
clinical trial data
Lung cancer
ADJUVANT CHEMOTHERAPY IN STAGE IB NON-SMALL CELL LUNG CANCER
(NSCLC): UPDATE OF CANCER AND LEUKEMIA GROUP B (CALGB) PROTOCOL
9633. ASCO 2006, ABSTRACT 7007.
LUNG ADJUVANT CISPLATIN EVALUATION (LACE):
A POOLED ANALYSIS OF FIVE RANDOMIZED CLINICAL TRIALS
INCLUDING 4,584 PATIENTS . ASCO 2006, ABSTRACT 7008.
ADJUVANT CHEMOTHERAPY IN ELDERLY PATIENTS:
AN ANALYSIS OF NATIONAL CANCER INSTITUTE OF CANADA CLINICAL
TRIALS GROUP AND INTERGROUP BR.10. ASCO 2006, ABSTRACT 7009.
Breast
cancer prevention
THE STUDY OF TAMOXIFEN AND RALOXIFENE (STAR ): INITIAL FINDINGS
FROM THE NSABP-2 BREAST CANCER PREVENTION STUDY. 2006 ASCO,
ABSTRACT LBA5.
Head and
neck cancer
LONG-TERM RESULTS OF INTERGROUP RTOG 91-11 : A PHASE III TRIAL
TO PRESERVE THE LARYNX — INDUCTION CISPLATIN /5-FU AND
RADIATION THERAPY VERSUS CONCURRENT CISPLATIN AND RADIATION
THERAPY VERSUS RADIATION THERAPY . ASCO 2006, ABSTRACT 5517.
Gastric
cancer
RANDOMISED MULTICENTRE PHASE III STUDY COMPARING CAPECITABINE
WITH FLUOROURACIL AND OXALIPLATIN WITH CISPLATIN IN PATIENTS
WITH ADVANCED OESOPHAGOGASTRIC (OG) CANCER: THE REAL 2 TRIAL.
ASCO 2006, Abstract LBA4017.
Rectal
cancer
ROUTINE SHORT COURSE PRE-OP RADIOTHERAPY OR SELECTIVE POST-OP
CHEMORADIOTHERAPY FOR RESECTABLE RECTAL CANCER? PRELIMINARY
RESULTS OF THE MRC CR07 RANDOMISED TRIAL. ASCO 2006, ABSTRACT
3511.
LOCAL RECURRENCE AFTER RECTAL CANCER
RESECTION IS STRONGLY RELATED TO THE PLANE OF SURGICAL DISSECTION
AND IS FURTHER REDUCED BY PRE-OPERATIVE SHORT COURSE RADIOTHERAPY.
PRELIMINARY RESULTS OF THE MEDICAL RESEARCH COUNCIL (MRC)
CR07 TRIAL. ASCO 2006, ABSTRACT 3512.
Multiple
myeloma
SUPERIORITY OF MELPHALAN-PREDNISONE (MP) + THALIDOMIDE (THAL)
OVER MP AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN THE TREATMENT
OF NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA
. ASCO 2006, ABSTRACT 1.
| 
